Peramivir
Paul G. Auwaerter, M.D., Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- FDA-approved for uncomplicated influenza in patients ≥ 6 months with symptoms present for less than 2 days.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of influenza for hospitalized adult and pediatric patients for whom therapy with an IV anti-influenza drug is needed.
- Hospitalized influenza when oral/enteric oseltamivir cannot be tolerated or reliably absorbed (off-label).
- Clinical benefit of peramivir has not been established in hospitalized patients.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.